Current And Forthcoming Sepsis Diagnostics Market Size In Terms Of Volume And Value 2019

 Global Sepsis Diagnostics Market Information, By Technology (Molecular Diagnostics, Biomarkers, Immunoassays and others), By Type of Product (Kits, Instruments, Blood Culture Media and others), By End Users (Pathology Laboratories, Specialty Clinics, Hospitals, Diagnostic Centers and others)- Forecast Till 2022

Global Sepsis Diagnostics Market 2019 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis.

Market Scenario:

An expert on premium research reports, Market Research Future has added a report titled "Global Sepsis Diagnostics Market 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Sepsis is a type of life-threatening organ dysfunction arises when the body's response to an infection injures its own tissues and organs. It can be caused due to weakened immune system, chronic illness, kidney or liver disease, cancer and severe wounds. It can be of two types severe sepsis when there’s organ failure and other is septic shock in which there are the symptoms of severe sepsis includes a low blood pressure. The hospital-acquired infections and rising prevalence of sepsis has led to a growing need for its early diagnosis, which is one of the driving factor for sepsis diagnostics market.

The global market for sepsis therapeutics market  is expected to reach USD 710 million by the end of the forecasted period and is expected to grow at a CAGR of 8%.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2110

Competitive Analysis

 

• bioMérieux, Inc.
• EKF Diagnostics
• Immunexpress
• T2 Biosystems, Inc.
• Becton
• Dickinson and Company
• Axis-Shield Diagnostics Ltd.
• Cube Dx GmbH
• Sandstone Diagnostics, Inc.

Study Objectives of Global Sepsis Diagnostics Market:

• To provide detail analysis of the market structure along with forecast for the next 7 years of various segments and sub-segments of the global sepsis diagnostics market.
• To provide insights about factors affecting the market growth.
• To analyze the market based on various factors which includes price analysis, supply chain analysis, Porters Five Force Analysis etc.
• To offer past as well as estimated future revenue of the market’s  segments and sub-segments with respect to four main geographies and their countries; these includes  Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and estimated future growth of the market.
• To give country level analysis of the market’s segments which includes by technology, by type of product, by end users and other sub segments.
• To provide overview about key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape for the market.
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, along with research and developments that is taking place globally.

Segmental Analysis

Global sepsis diagnostics market has been segmented on the basis of technology which comprises molecular diagnostics, biomarkers, immunoassays and others. On the basis of type of product product types; the market is segmented into kits, instruments, blood culture media and others. On the basis of end users the market is segmented into pathology laboratories, specialty clinics, hospitals, diagnostic centers and others.

Regional Analysis

Globally North America is the largest market for medical tourism. The North American market for sepsis diagnostics is expected to reach USD 320 million by the end of the forecasted period.

Europe is the second largest market for sepsis diagnostics which is expected to grow at the CAGR of 6.8%. Asia Pacific is expected to be fastest growing region in sepsis diagnostics market.

The report of global sepsis diagnostics market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and projected future market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. Along with all these detail information and strategies about top key players in the industry is also given. Further a broad study of different markets segments and regions is also provided.

Industry Updates:

Dec 2018 Beckman Coulter, which is an international leader in the clinical diagnostics industry has announced that it is joining forces with Sepsis Alliance, the nation's leading sepsis organization, to support the Sepsis Coordinator Network. The pioneering online, peer-to-peer alliance for healthcare professionals, the Sepsis Coordinator Network is dedicated to saving lives by advancing patient results.

May 2018 Mobidiag, a Finnish firm, has obtained funding to creäte a rapid molecular sepsis assay on its Novodiag system. The fresh funding comprises of a €1.5 million ($1.74 million) loan for the first year of the project provided by Business Finland, a funding agency previously known as Tekes.

Access More Details of the Report @  https://www.marketresearchfuture.com/reports/sepsis-diagnostics-market-2110 

Latest Study Offers Detailed Insights On Regenerative Medicine Market 2019

 The Global Regenerative Medicine Market is growing steadily. Factors that influence the regenerative medicine market are increasing advancement in healthcare technology, increasing advance technology in regenerative medicine market, increasing prevalence of chronic diseases, increasing growth in stem cell technology and others. Globally  regenerative medicine market growth is expected to grow at the rate of about 25.4% from 2016 to 2022.

 

Investments are likely to flow towards the regenerative medicine industry over the next couple of years. In addition, the support extended by the government for drug development is poised to revolutionize the future trajectory of the global market. It is also likely to benefit from technological advancements in the market.

 

Stem cell technology is gaining traction in the healthcare sector. Its accelerated adoption in the field of medical science is also anticipated to have a favorable impact on the expansion of the regenerative medicine market. The players of the market are forecasted to capitalize on the gap prevailing between the demand and supply for organs. However, factors such as stringent regulations, and the high cost of the treatment are expected to check the proliferation of the regenerative medicine market through the projection period.

Market Segmentation:

on the basis of material, the regenerative medicine market has been segmented into synthetic materials, genetically engineered materials, pharmaceuticals, biologically derived materials, and others.

On the basis of therapy, the global regenerative medicine market has been segmented into stem cell biology, cellular therapy, tissue engineering, and others.

On the basis of application, the regenerative medicine market has been segmented into cord blood, oncology, urology, orthopedics, neurology, dermatology, cardiovascular, orthopedic and others.

Competitive Dashboard:

Some of the key players profiled in the report are Cook Biotech, Organogenesis, Stryker and RTI surgical, Baxter International, Inc., Osiris Therapeutics, CryoLife, Sanofi, LifeSciences, Advanced Cell Technology, BioMimetic Therapeutics, LifeCell Kinetic Concepts, StemCellsInc, and Medtronic.

Regional Analysis:

The global regenerative medicine market, by region, has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is currently holding the largest share of the market, accounting for 44% share. It is expected to grow significantly at a CAGR of 22.3% during the forecast period. The factors such as developments in healthcare technology, presence of advanced healthcare infrastructure, increasing burden of chronic diseases, etc.

Europe has gained control over the second-largest share of the market. It is expected to strike a high CAGR of 22.5% over the assessment period. The availability of funds coupled with the government’s support is likely to accelerate research & development activities. This, in turn, is prognosticated to boost the growth trajectory of the regional regenerative medicine market in the upcoming years.

Asia Pacific is a highly lucrative market and is expected to remain so across the review period. The rapid developments in the healthcare sector and growing patient pool are anticipated to drive the expansion of the regenerative medicine market in the region. It is estimated to mark a relatively higher CAGR and emerge as the fastest growing regional market in the foreseeable future.

Industry News:

In November 2018, 3D.FAB, a French additive manufacturing platform, has announced that it is working on the development of a “living bandage” using direct additive manufacturing and 3D bioprinting for treating damaged tissues.

In December 2018, Food and Drug Administration has sent Genetech, a CA-based biotechnology subsidiary of Roche, and other firms and providers offering stem cell treatments warning letters to notify about agency's regenerative medicine policy framework.

Browse More Details of the Report @

Browse more Pharmaceutical Reports @ https://www.marketresearchfuture.com/categories/pharmaceutical-market-report

North America Microarray Market Trends, Analysis And Review During 2019 To 2023

 Market Scenario:

North America the market for Microarray is increasing rapidly. A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development. North American market for Microarray is expected to grow at the rate of about 4.0% from 2016 to 2027.

Key Finding

• The North America microarray market size is expected to reach $1,635.4 billion by 2027.
• Paraffin tissue sections (FFPE) hold the largest share of 54.6% of the North America Tissue Microarray market.
• U.S. holds the largest market share of North America Tissue Microarray market and is anticipated to reach $364.2 million by the end of 2027.
• Immunohistochemistry segment holds the largest market share of 47.5% in 2015.

Segments:                                                                                                                                        
North America Microarray market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray. On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others. On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2641 

Regional Analysis of North America Microarray Market:                                                                 
In North America, U.S. is the largest market for Tissue Microarray. Canada is the second-largest market and is expected to be fastest growing market for Tissue Microarray in North America.

Key Players for North America Microarray Market:                                                               
Some of the key players in this North America Microarray Market are: ABCAM, ASTERAND BIOSCIENCE, IHC WORLD LLC, NOVUS BIOLOGICALS LLC (ACQUIRED BY BIO-TECHNE), ORIGENE TECHNOLOGIES INC, PANTOMICS, INC, PROTEIN BIOTECHNOLOGIES INC, US BIOMAX, INC., US BIOUPTON INT, VITROVIVO BIOTECH, LLC and others.

Access More Details of the Report @   https://www.marketresearchfuture.com/reports/north-america-microarray-market-2641 

Global Wound Closure Device Market Production, Capacity, Revenue, Price, Gross Margin Analysis And Forecast 2019-2023

 Market Scenario:

The timely treatment of wounds has progressed to incorporate non-invasive, disposable, and sterile wound closure solutions. Reports that assess the healthcare industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts. The market is anticipated to accomplish a CAGR of 6.9 % in the forecast period.

The development of medical devices and treatment procedures for trauma-related injuries is motivating the wound closure device market. The rise in the volume of surgical procedures has increased the market share of the wound closure device market size considerably. The upswing in the cases of trauma, burns, and accidents is stimulating the market for wound closure devices. 

Moreover, advancement in technology, decrease in a number of surgical site infections and attempts to reduce hospital stays for reducing surgical expenditure is contributing to the growth of the market. According to a survey conducted by the American Professional Wound Care Association (2017), chronic nonhealing wounds impact nearly 15% of Medicare beneficiaries (8.2 million). The estimated spending for primary wound diagnosis is USD 28 billion per year and the cost for secondary wound diagnosis is estimated to be USD 31.7 billion.  

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2001

The risk associated with infectious wounds, side effects of wound closure devices, and unfavorable reimbursement policies may hamper the growth of the market during the assessment period.

Key Players

• 3M,
• Abbott Laboratories,
• Braun Melsungen AG,
• Ethicon Inc.,
• ,
• Smith & Nephew,
• Baxter International,
• BSN medical Inc.,
• Derma Sciences,
• Kinetic Concepts,
• ConvaTec,
• DACH Medical Group,
• Arthrex GmbH,
• Gecko Biomedical,
• Integra LifeScience,
• CP Medical.

Segmentation

The global wound closure device market has been segmented based on device, application, type of wound, and end-user.

On the basis of device, the market has been classified into adhesives, staples, sutures, and mechanical wound closure devices. Adhesives are furthers classified into fibrin tissue adhesives and cyanoacrylates. The sutures segment has been further divided into absorbable, non- absorbable, braided, and monofilament.

On the basis of application, the market has been classified into burns, ulcers, surgical wounds, pressure ulcers, diabetic ulcers, and arterial ulcers. On the basis of type, the surgical wounds segment has been sub-segmented into chronic wounds, acute wounds, and others.

The market, by end-user, has been segmented into hospitals, community healthcare service providers, ambulatory surgical centers, and home care.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The wound closure device market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European wound closure device market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The wound closure device market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

The wound closure device market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

The Americas is likely to hold the majority of the global wound closure device market owing to increase in the number of surgical procedures, increasing injuries related to accidents, sports and adventure, aging population, the presence of a well-established healthcare system, and adoption and awareness of the wound closure technology. According to the American Association for the Surgery of Trauma, injury accounts for over 150,000 deaths and over 3 million non-fatal injuries are reported per year in the US.

The European market is expected to be the second-largest wound closure device market after the Americas. The market growth in this region can be attributed to an increase in aged population and rising occurrence of sports injuries and accidents. Moreover, the growing number of road accidents in the European region are contributing to the growth of the market in this region. According to data published by the European Commission in 2018, more than 135,000 people suffered serious injury from road accidents.

Asia-Pacific is expected to be the fastest-growing wound closure device market during the forecast period owing to the significant increase in aged population, increasing prevalence of chronic diseases such as diabetes leading to the increasing cases of diabetic foot ulcer. According to WHO, there are more than 96 million diabetics patients in the Asia-Pacific region.

The market in the Middle East and Africa is expected to account for the smallest share of the global wound closure device market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Access More Details of the Report @  https://www.marketresearchfuture.com/reports/wound-closure-device-market-2001 

Cardiovascular Needle Market - Granular Market Report And Review, 2019

 Market Insights:

According to the International Diabetes Federation in 2016, it was estimated that 420 million adult population had diabetes, which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040. Furthermore, increasing prevalence of population suffering from cardiovascular diseases, diabetes, and obesity driving the growth of the cardiovascular needles market globally.

The global cardiovascular needles market size is growing rapidly owing to its application in various fields such as open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.

According to the World Health Organization (WHO) in 2015, around 1.6 million deaths were directly caused by diabetes and in 2014, 8.5% of adults aged 18 years and older had diabetes. Thus, rising prevalence of chronic diseases is majorly driving the global cardiovascular market.

 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1234

 

According to the World Health Organization (WHO), in 2015, around 17.7 million people died from cardiovascular diseases, which represents 31% of all global deaths. Of these deaths, around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

 

Various factors are adding fuel to the growth of the global cardiovascular needle market, such as unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market.

 

Moreover, advancing technology in the medical devices is adding fuel to the growth of the market. Furthermore, increasing government support in the developing countries drive the market growth.

 

However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.

The global cardiovascular needle market is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.

Key Players

Some of the key the players in the market are Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)

Segmentations

The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.

On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles.  

On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.  

On the basis of the usage, it is segmented into single use and multiple uses.

On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Regional Analysis

The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.

Europe holds the second position in the global cardiovascular needle market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.

The Asia Pacific is the fastest growing Cardiovascular Needle market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.

On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.

Access More Details of the Report @ https://www.marketresearchfuture.com/reports/cardiovascular-needle-market-1234 

Enema Bags Market Dynamics, Forecast, Analysis And Supply Demand 2019

 Market Scenario:

Some health problems due to unhealthy eating, drinking in lifestyle may not be fatal but they can a hard time to the body they occur in. One such problem is constipation. A common remedy for constipation is an enema. Apart from constipation, enema provides relief from backaches, fatigue, and headaches. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly. A remedy helpful for many health problems always grows rapidly as a market. The factors driving the market growth include rising chronic diseases in an aging population with cancer and diabetes coupled with the increasing prevalence of gastrointestinal disorders and growing awareness about enema administration. Home care is advisable to be administered only after the advice of the clinician. Factors that can cause roadblocks to the growth of global enema bags market include the possibility of newer methods of enema treatment and environmental concerns raised from the bags that are made up of silicone, rubber, etc.

Enema is the process of injecting fluid into the bowel via the rectum. This method is used to get relief from various conditions such as constipation, fatigue, headaches, and backaches. It is a process that helps to push out the waste from the rectum. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly.

The Global Enema Bag Industry Industry is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global enema bags market is expected to register a CAGR of ~ 10.2 % during the forecast period of 2018–2023.

Enema can be administered at hospitals as well as in home. This technique is also preferred before performing bowel procedures such as radiography and colonoscopy. The most common gastrointestinal condition affecting people nowadays is constipation with the ever-rising prevalence across the globe. Furthermore, the use of enema based products for bowel cleansing is growing extensively.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1363

However, certain disrupting factors that might restrain the growth of enema bags include the possibility of newer methods of enema treatment. Moreover, there might be environmental issues as the bags are made up of silicone, rubber, etc.

Segmentation

The global enema bags market is segmented on the basis of the material type, product type, application, capacity, and end-user.

On the basis of material type, the market is classified into silicone, rubber, and others.

On the basis of administration type, the market is segmented into cleansing enema, carminative enema, retention enema, return-flow enema, and others. Cleansing enema is further segmented into large volume enema, small volume enema, and prepackaged disposable enema. Retention enema is further segmented into oil enema, sedative enema, nutrient enema, anesthetic enema, medicinal enema, and others.

The global enema bags market on the basis of product type is segmented into closed or bottle enema, Higginson enema, bulb enema, bag or fountain travel enema, and others.

On the basis of indication, the market is segmented into constipation, diarrhea, obesity, cancer, and others.

On the basis of preparation, the market is divided into sodium phosphate enemas, coffee enemas, barium enemas, water-soluble contrast enemas, and others. Barium enemas are further segmented into single-column barium enema and double-contrast barium enema.

On the basis of application, the market is segmented as bowel clearing, contrast x-ray, medication administration, and others.

On the basis of capacity, the market is segmented into 100 to 250 ml, 250 to 400 ml, 400 to 600 ml, and others.

On the basis of end-user, the global enema bags market is segmented into hospitals, clinics, research centers, and others.

Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American enema bags market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.

The European enema bags market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the rest of Western Europe. 

The Asia Pacific enema bags market is segmented into Japan, China, India, Republic of Korea, Australia, and the rest of Asia Pacific.

The Middle Eastern and African enema bags market is segmented into the Middle East and Africa.

Top Key Players             

The key players in global enema bags market are Baxter International, Inc. (the USA), B Braun Melsungen AG (Germany),  Cascade Healthcare Products, Inc. (the USA), Coloplast A/S (Denmark), Covidien Private Ltd. (Ireland), Farla Medical Ltd. (UK), Flexicare Medical Limited (UK), Hollister Incorporated (USA), MacoPharma (France), Medline Industries, Inc. (USA), Narang Medical Ltd. (India), Ocean Health Products Ltd. (Singapore), and Qingdao Sinoland International Trade Co., Ltd. (China).

Regional Market Summary

Globally, the American region is the largest market for enema bags owing to the high level of hygiene developed in hospitals and clinics, increasing use of enema-based products at home, and rising demand for enema kits by healthcare providers. As per a study conducted by the Canadian Journal of Gastroenterology, constipation is a common problem among the people in the North American region. Moreover, the study stated that 20% of the North American population suffers from constipation.

Asia Pacific and North America are expected to collectively dominate the enema bags market in terms of volume and value, respectively, due to the increase in awareness towards abdominal diseases and high demand from the pharmaceutical and healthcare industry. The U.S. has the largest market of enema bags in the North American region and countries such as India and China are the highest producers of enema bags in the Asia Pacific region. The factor influencing the growth is the increasing prevalence of chronic diseases such as obesity and diabetes. Currently, the major problem in China and India is diabetes. India had the world’s second-largest population of diabetic patients that was around 69.2 million in 2015 which is expected to increase to 123.5 million by 2040. The number of undiagnosed diabetes is higher in India which was around 36 million in 2015.

The European market is growing due to the increasing prevalence of diarrhea, obesity, and constipation. Increasing cases of enema administration procedures in hospitals are contributing to the progress of the market. The prevalence of diabetes is also found to be increasing in Europe. As per a study published by the World Health Organization, almost 60 million people in the European region have diabetes, and the prevalence tends to be high among people aging 30 years and above.

The Middle East and Africa also shows a steady rise in the market owing to the availability of enema-based products, lack of physical exercise, and increasing cases of constipation.

Access More Details of the Report @ https://www.marketresearchfuture.com/reports/enema-bag-market-1363 

Spinal Needles Market - Demand, Growth, Opportunities And Analysis Of Top Key Player Forecast To 2023

 Market Scenario

The spinal needles industry is expected to register 7.2% CAGR during the forecast period, 2019 to 2025. The market was valued at approximately USD 207.6 million in 2018.

Spinal needles are medical equipment that is generally used for diagnostic or therapeutic purposes. These needles are inserted into the spinal canal for the collection of cerebrospinal fluid (CSF) for diagnostic testing or drug administration for the treatment of diseases. The sample collected is mainly used for diagnosing diseases related to the central nervous system.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1216

Segmentation

The global spinal needles have been segmented based on type, application, end-user, and region. The global market, based on type, has been segmented into atraumatic needles, directional spinal needles, and pencil-point needles. The pencil-point needles segment is expected to be the largest segment, owing to the increasing adoption of the pencil-point needles.

The global market, based on application, has been bifurcated into therapeutic and diagnostic. The therapeutic segment is expected to be largest, in terms of value, due to the increasing prevalence and diagnosis of brain and spinal diseases.      

The global market, based on end-user, has been segmented into hospitals & clinics, diagnostic centers, research laboratories, and others. Hospitals and clinics are the largest end-users of spinal needles market. The hospitals & clinics segment is anticipated to hold a major share of the market during the forecast period due to the growing geriatric population and increasing prevalence of neurodegenerative disorders.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The spinal needles market in the Americas has further been divided into North America and Latin America. In North America, the market is bifurcated into the US and Canada. The European spinal needles market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, Italy, Spain, the UK, and the rest of Western Europe. The spinal needles market in Asia-Pacific has been segmented into Japan, China, India, South Korea, and Australia. The spinal needles market in the Middle East & Africa has been divided into the Middle East and Africa

Key Players

The key players operating in the global spinal needles market are Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic plc., EXELINT International, Co., Smiths Medical, Stryker Corporation, ARGON MEDICAL, Myco Medical, Cook Medical, and Novo Nordisk A/S. 

Regional Market Summary

The market in the Americas is projected to have a steady growth rate during the forecast period owing to the increasing number of patients with spinal diseases and government initiatives for healthcare reforms. Moreover, there is an increase in the use of these needles by healthcare physicians. According to the American Chiropractic Association, in 2017, one-half of all working Americans admit to having symptoms of back pain every year. Moreover, approximately 17,730 new spinal cord injuries occur each year. Thus, the increasing cases of spinal injuries would ultimately drive the demand for spinal needles in the region.

The market in Europe showed substantial growth during the forecast period. The market growth in this region can be attributed due to the rise in the number of spinal surgeries. According to the World Health Organization (WHO), spinal surgeries increased by 77% in the last five years. Moreover, the rising healthcare expenditure is expected to drive the growth of spinal needles market in this region.

The market in Asia-Pacific is expected to dominate the spinal needles market due to the increasing investment in the development of healthcare infrastructure. Moreover, there is an increase in the number of patients suffering from spinal disease, including spondylitis. Such factors are driving the growth of the spinal needles market in this region.

The market in the Middle East & Africa is expected to grow at a substantial rate due to the increase in the use of surgical treatment for spinal diseases in the region.

Latest Industry News

• Abacus Finance Group LLC has provided senior debt financing to support Zavation Medical Products LLC’s acquisition of Tampa, Florida-based Pan Medical US Corp, a maker of medical products used in minimally invasive procedures. 22 OCT 2018
• Two University of Virginia alumni have built a new spine-finding device that is giving the practice of identifying the correct insertion point for epidurals and other forms of spinal anesthesia, a much-needed upgrade. 14 JUNE 2018

Access More Details of the Report @  https://www.marketresearchfuture.com/reports/spinal-needles-market-1216